BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2006
View Archived Issues
Genzyme presents overview of quarterly activities
Read More
Study results detail entecavir efficacy in hepatitis B
Read More
Clevudine effective in hepatitis B patients treated for 1 year
Read More
Objective responses seen with A-007 in cutaneous cancer metastases
Read More
Spotlight on clinical progress of OROS-Hydromorphone for pain syndromes
Read More
Chugai updates recent developments
Read More
Prous Science online journals add multimedia component
Read More
Dendritic RNA transport granule proteins postulated to play a role in nociception
Read More
Sirna and GlaxoSmithKline begin programs in asthma and RSV
Read More
Acenta developing NAAG peptidase inhibitors for brain injury
Read More
Remoxy begins phase III program
Read More
Manhattan to study oleoyl-estrone for obesity in phase IIa study
Read More
Formulation difficulties for Manhattan's topical PTH (1-34)
Read More
OxyPharma obtains funding to advance ROB-803 into phase II
Read More
Heparins interfere with P-selectin binding and block metastasis
Read More
Nonproprietary name lorcaserin hydrochloride approved for APD-356
Read More
SkyePharma and Kos sign agreement for Flutiform
Read More
Celtic cleared in U.K. to begin phase II study of TA-NIC
Read More
Topline data support use of Frova in prevention of menstrual migraine
Read More
CancerVax and Micromet complete merger
Read More
Positive phase III findings for Evamist
Read More
Phase III trial of H5N1 influenza pandemic vaccine cleared to begin in Spain
Read More
NDA submission for Gestiva for prevention of preterm birth
Read More
PBT-2 well tolerated in phase I program
Read More
Novel analgesic agents imparted in recent patent literature
Read More
New therapeutics for neurological disorders reported in recent patents
Read More
Enjuvia now available in U.S.
Read More
Preliminary clinical results on GTI-2040 published
Read More
New patents cover novel antidiabetic agents
Read More
Snapshots of potential treatments for uveal melanoma
Read More
Novel neuroprotective strategies in glaucoma therapeutics - Part I
Read More